Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today    sector : N::A    symbols : Tevjf    save search
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.65 1.87% 120K twitter stocktwits trandingview |
n/a
 | | O: 2.16% H: 0.0% C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M twitter stocktwits trandingview |
Health Technology
 | | O: -1.02% H: 0.0% C: 0.0%
avt05 simponi biosimilar for topline results study
Gainers vs Losers
54% 46%

Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M twitter stocktwits trandingview |
Consumer Services
CZOO | $11.04 121.24% 9.6M twitter stocktwits trandingview |

BOF | $2.05 75.21% 78M twitter stocktwits trandingview |

AMST | $3.2 60.0% 63M twitter stocktwits trandingview |
Technology Services
LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.05 44.75% 13M twitter stocktwits trandingview |
Technology Services
TROO | $1.51 38.53% 5.6M twitter stocktwits trandingview |
Manufacturing
MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information
RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance
RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.